课题基金 / 基金详情

Cancer Center Clinical Trials Reporting Program (CTRP) Early Adopters

Cancer Center Clinical Trials Reporting Program (CTRP) Early Adopters
癌症中心临床试验报告计划 (CTRP) 早期采用者
批准号:
7923465
负责人:
Riccardo Dalla-Favera
金额:
$9.99万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-04 至 2013-06-30

项目摘要

项目成果

Riccardo Dalla-Favera的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Herbert Irving Comprehensive Cancer Center (HICCC) was designated an NCI Cancer Center in 1972 and gained comprehensive status in 1979. The HICCC is a component of Columbia University Medical Center and associated with New York-Presbyterian Hospital (NYPH). During the period 2003-07, CUMC and NYPH have committed over $312.7 million for i) new research initiatives in basic, clinical and population science; ii) new and expanded facilities for laboratory research and clinical activities; iii) recruitment and program restructuring; iv) support of the Center's administrative office; and v) bridge funding to offset reduced NCI CCSG support. A new Director, Riccardo Dalla-Favera, MD, was appointed in 2005 and given: i) authority over new facilities, including the Irving Cancer Research Center (ICRC), a new 10-story building dedicated to cancer research, with state-of-the-art laboratories (100,000 square feet) and incremental clinical (30,000 square feet) space in the Herbert Irving Pavilion (HIP); ii) a broad-based recruitment plan, which has already attracted 8 new faculty members to the HICCC; and iii) restructuring and expansion of the shared resources. The Director has fully reshaped the senior leadership of the HICCC with appointments of a Deputy Director for Clinical Research and Associate Directors for Basic Research, Clinical Research, Population Science, Biomedical Informatics, Shared Resources and Administration. The programmatic structure of the HICCC has been reorganized to increase cancer focus and interdisciplinary collaboration, and now includes 216 members from 22 Departments and 6 Schools, assigned to two Basic Research programs (Cancer Signaling Networks and Cancer Genetics & Epigenetics), three Disease-Specific programs (Breast Cancer, Prostate Cancer, and Lymphoid Development & Malignancy), and two Population Science programs (Cancer Epidemiology and Prevention, Control & Disparities). The HICCC administers and supports a total of 12 Shared Resources, of which four have been recently created.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
From pathogenesis to new therapeutic targets in diffuse large B cell lymphoma
MSK SPORE in Lymphoma
  • 批准号:
    9753960
  • 项目类别:
  • 资助金额:
    $209.4万
  • 财政年份:
    2016
  • 负责人:
    Riccardo Dalla-Favera
  • 依托单位:
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma
海外基金